Skip to main content

What the FDA labels say about taking them together

Fentanyl and fosamprenavir

Fosamprenavir's FDA label of September 15, 2023 names fentanyl in its drug interactions section; the fentanyl labels PlainMeds reads (2) do not name fosamprenavir. The fosamprenavir label: “Careful monitoring of therapeutic effects and adverse effects of fentanyl is recommended.”

Check it at the source: the fentanyl FDA label on DailyMed (effective March 6, 2026, Hikma Pharmaceuticals USA Inc.); the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.).

What does the fentanyl label say about fosamprenavir?

Fentanyl's label (effective March 6, 2026) and its 1 other brand-application label do not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fentanyl Citrate), Hikma Pharmaceuticals USA Inc., effective March 6, 2026 (SPL set ce5db1c2-feb1-4ad2-847a-d02e865bd47e), via openFDA; the full label on DailyMed

What does the fosamprenavir label say about fentanyl?

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: Fentanyl; Effect on Concentration of Amprenavir or Concomitant Drug: ↑ Fentanyl; Clinical Comment: Careful monitoring of therapeutic effects and adverse effects of fentanyl (including potentially fatal respiratory depression) is recommended.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Fentanyl generic labelers
2Fosamprenavir generic labelers
FentanylFosamprenavir
Labeled forPainHIV
Boxed warningYesNo
Pharmacy cost (NADAC)$1.79 per mL 100 mcg/2 mL vialn/a
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?